Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATCH: R-EPOCH and cART in AIDS-related lymphoma
NCT00799136Phase 2Completed
- Sponsor
- Ontario Clinical Oncology Group
- Start
- Feb 2008
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, etoposide, doxorubicin, vincristine, cyclophosphamide in lymphoma, human immunodeficiency virus infection (HIV), sponsored by Ontario Clinical Oncology Group. Started Feb 2008; status: completed.
02
Drugs
rituximabetoposidedoxorubicinvincristinecyclophosphamide
03
Conditions
lymphomahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00799136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799136.